Genomic analysis of castration sensitive and resistant prostate cancer patients by multiple-gene targeted sequencing

Genomic analysis of castration sensitive and resistant prostate cancer patients by multiple-gene targeted sequencing

Bibliographic Details
Main Authors:	L. Fan, B. Dong, W. Xue
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320331736

Similar Items

Treatment sequencing in metastatic castrate-resistant prostate cancer
by: Oliver Sartor, et al.
Published: (2014-06-01)

Circulating tumor DNA targeted sequencing reveals germline and somatic alterations that can guide decision making in metastatic castration-resistant prostate cancer
by: B. Dong, et al.
Published: (2020-07-01)

Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer
by: Jong-Lyul Park, et al.
Published: (2018-09-01)

Prognostic significance of time to castration resistance in patients with metastatic castration-sensitive prostate cancer
by: Y. Matsushita, et al.
Published: (2020-07-01)

Castration-resistant prostate cancer: potential targets and therapies
by: Parray A, et al.
Published: (2012-08-01)

Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
by: Teresa Maria Santos Amaral, et al.
Published: (2012-01-01)

Emerging targeted therapies for castration-resistant prostate cancer
by: Vincenzo eAdamo, et al.
Published: (2012-05-01)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2016-03-01)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2016-01-01)

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer
by: Cedric Pobel, et al.
Published: (2021-09-01)

Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
by: Wout Devlies, et al.
Published: (2020-11-01)

Darolutamide For Castration-Resistant Prostate Cancer
by: Bastos DA, et al.
Published: (2019-10-01)

Response and Resistance in Castration-Resistant Prostate Cancer
Published: (2020)

Differences in genomic profiles between Chinese and Caucasian castration-resistant prostate cancer
by: L. Ke, et al.
Published: (2020-07-01)

Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy
by: Inna Armandari, et al.
Published: (2014-09-01)

Novel Target Opportunities in Non-Metastatic Castrate Resistant Prostate Cancer
by: Stephanie Gleicher, et al.
Published: (2021-05-01)

Gene Expression Profiling Analysis Reveals Putative Phytochemotherapeutic Target for Castration-Resistant Prostate Cancer
by: Solomon Oladapo Rotimi, et al.
Published: (2019-08-01)

Sequencing of Cabazitaxel in Metastatic Castrate-Resistant Prostate Cancer: A Case Report
by: Donald Colbourn
Published: (2012-06-01)

Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens
by: Jessica J. Nunes, et al.
Published: (2017-04-01)

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact
by: Lisanne F. van Dessel, et al.
Published: (2019-11-01)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
by: Lixin Mai, et al.
Published: (2020-12-01)

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
by: Renée de Leeuw, et al.
Published: (2020-10-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

Reappraisal of glucocorticoids in castrate-resistant prostate cancer
by: Oliver Sartor, et al.
Published: (2014-10-01)

Chemotherapy options in castration-resistant prostate cancer
by: Benjamin A Teply, et al.
Published: (2016-01-01)

Optimal treatment for castration-resistant prostate cancer
by: Kouji Izumi, et al.
Published: (2014-06-01)

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
by: Joelle El-Amm, et al.
Published: (2013-01-01)

Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
by: Paul S. Rennie, et al.
Published: (2013-06-01)

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
by: Maria Massaro, et al.
Published: (2021-09-01)

Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate Cancer
by: Agus Rizal A. H. Hamid, et al.
Published: (2021-08-01)

Reinduction of Hormone Sensitivity to Goserelin following Chemotherapy with Vinorelbine in Castration-Resistant Prostate Cancer
by: Tal Grenader, et al.
Published: (2010-01-01)

FABP5-related signalling pathway used as therapeutic target for castration-resistance prostate cancer
by: Al-Jameel, W. H.
Published: (2017)

Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
by: Yundong He, et al.
Published: (2016-12-01)

Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer
by: Dan Su, et al.
Published: (2021-01-01)

Update on options for treatment of metastatic castration-resistant prostate cancer
by: Prakash Vishnu, et al.
Published: (2010-03-01)

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
by: Magbanua Mark, et al.
Published: (2012-02-01)

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
by: Tucci M, et al.
Published: (2018-10-01)

Recent Progress in Pharmaceutical Therapies for Castration-Resistant Prostate Cancer
by: Qingzhong Hu, et al.
Published: (2013-07-01)

Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
by: Jianwei Zheng, et al.
Published: (2020-12-01)

Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves.
by: Francesca Marano, et al.
Published: (2016-01-01)